RXST · Company research
RxSight, Inc. Common Stock (RXST): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A sales leader with over 30 years in eye care joins RxSight. - Stock Titan | A sales leader with over 30 years in eye care joins RxSight. Stock Titan | View source ↗ | Stock Titan | Oct 19, 2026 | neutral | 0 | 0.6 |
| K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world | K2 Vision, a Pacific Northwest and Arizona-based vision correction practice, has completed 5,000 Light Adjustable Lens (LAL) procedures and been recognized by RxSight as the world's highest-volume LAL practice. The LAL is the first lens implant that can be adjusted after placement through noninvasive light treatments, allowing for customized vision correction based on patient needs. | View source ↗ | GlobeNewswire Inc. | Oct 16, 2026 | bullish | 1 | 1 |
| K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world | K2 Vision, a Pacific Northwest and Arizona-based vision correction practice, has completed 5,000 Light Adjustable Lens (LAL) procedures and been recognized by RxSight as the world's highest-volume LAL practice. The LAL is the first lens implant that can be adjusted after placement through noninvasive light treatments, allowing for customized vision correction based on patient needs. | View source ↗ | GlobeNewswire Inc. | Oct 16, 2026 | bullish | 1 | 1 |
| Insider Sale: Chief Medical Officer of $RXST Sells 5,100 Shares - Quiver Quantitative | Insider Sale: Chief Medical Officer of $RXST Sells 5,100 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 3, 2026 | neutral | 0 | 0.6 |
| RxSight management is scheduled to speak in Boston on Sept. 9 - Stock Titan | RxSight management is scheduled to speak in Boston on Sept. 9 Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| RxSight (NASDAQ: RXST) ex-director to sell 11,890 shares - Stock Titan | RxSight (NASDAQ: RXST) ex-director to sell 11,890 shares Stock Titan | View source ↗ | Stock Titan | Aug 18, 2026 | neutral | 0 | 0.6 |
| RxSight (RXST) offers to swap 4.08M underwater options for new awards - Stock Titan | RxSight (RXST) offers to swap 4.08M underwater options for new awards Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| RxSight (RXST) Stock Faces Margin Strain After Guidance Withdrawal - Simply Wall Street | RxSight (RXST) Stock Faces Margin Strain After Guidance Withdrawal Simply Wall Street | View source ↗ | Simply Wall Street | Aug 7, 2026 | neutral | 0 | 0.6 |
| RxSight (RXST) Stock Fair Value Falls After Soft Q2 Trends And Guidance Cut - Yahoo Finance | RxSight (RXST) Stock Fair Value Falls After Soft Q2 Trends And Guidance Cut Yahoo Finance | View source ↗ | Yahoo Finance | Jul 25, 2026 | neutral | 0 | 0.6 |
| RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance | RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 17, 2026 | neutral | 0 | 0.6 |
| RxSight: After Dropping To The Bottom, It's Time To Pick It Up (NASDAQ:RXST) - Seeking Alpha | RxSight: After Dropping To The Bottom, It's Time To Pick It Up (NASDAQ:RXST) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 10, 2026 | neutral | 0 | 0.6 |
| RxSight sees Q2 sales of $27M as Alcon deal adds revenue - Stock Titan | RxSight sees Q2 sales of $27M as Alcon deal adds revenue Stock Titan | View source ↗ | Stock Titan | Jul 6, 2026 | neutral | 0 | 0.6 |
| RXST Forecast — Price Target — Prediction for 2027 - TradingView | RXST Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 27, 2026 | neutral | 0 | 0.6 |
| RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance | RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | May 6, 2026 | neutral | 0 | 0.6 |
| How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets - Yahoo Finance | How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets Yahoo Finance | View source ↗ | Yahoo Finance | May 3, 2026 | neutral | 0 | 0.6 |
| RxSight, Inc. Common Stock (RXST) Stock Price: Oct 12 Close $4.66 - Gotrade | RxSight, Inc. Common Stock (RXST) Stock Price: Oct 12 Close $4.66 Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.